NCT00002226View on ClinicalTrials.gov

Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma

NACompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

Not specified

Conditions

Sarcoma, KaposiHIV Infections

Interventions

DRUG

SU5416

Trial Locations (4)

10016

New York Univ Med Ctr, New York

90033

Norris Cancer Ctr / USC, Los Angeles

94109

Saint Francis Mem Hosp / HIV Care Unit, San Francisco

900951793

UCLA Care Ctr / Ctr for Hlth Sciences, Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors

lead

SUGEN

INDUSTRY